Dong Zhang

dong1

ALT therapeutics

Affiliations

New York Institute of Technology

Technologies

Therapeutic

Indication

Oncology

Executive Summary

View/Download

We discovered that inhibition of FANCM prevents the survival of ALT cancers (10-15% of cancers) and planned to develop FANCM inhibitors to treat ALT cancers.

2020 PITCH DAY VIDEO

Newsletter Signup

Corporate Supporters

Community Service Providers